SIMSLab is developing label-free, optical protein sensors for a variety of applications. Current methods for protein detection, such as enzyme-linked immunosorbent assay (ELISA) and the western blot, require trained personal, numerous reagents and equipment, and a large amount of time. Therefore, the SIMSLab is developing a portable protein sensing platform that can be used in the field for rapid protein detection by non-technical personnel.
The protein sensing platform they have developed is based on localized surface plasmon resonance (LSPR) of metal nanoparticle arrays. Metal nanoparticle arrays are fabricated on glass using NSL or EBL (Fig. 13). Flow cells made of Polydimethylsiloxane (PDMS) are used along with a flow injection system to deliver samples to the nanoparticle array (Fig. 14). A simple white light source, spectrometer, and netbook are used to detect changes in the LSPR peak position upon protein binding (Fig. 15). The particle surfaces are functionalized with specific antibodies to capture only the proteins of interest. The prototype device is in a benchtop format, but is currently being developed into a portable system.
The advantages of the SIMSLab protein sensing platform are:
- Label free technology
- Low cost, batch fabrication sensors
- Simple hardware requirements
- Suitable for a wide variety of proteins and other biomolecules
- Quantitative concentration readings with high specificity and sensitivity, and a low detection limit (ng/mL)
- Measurement of protein kinetics
- Minimal sample preparation
- Robust against vibration, electromagnetic noise, and temperature fluctuations
- Easily integrated into a handheld or portable device format
- Fast response possible (less than 30 minutes)
Protein sensor for Heat shock protein 70 (HSP70)
HSP70 is a molecular chaperone protein, which performs multiple functions inside of cells, including protein translocation, stabilization and refolding of denatured proteins, higher order protein assembly, and degradation of irreversibly denatured proteins. HSP70 is an excellent marker of environmental health as it is highly conserved among species and upregulated in response to external stress stimuli, such as elevated environmental temperature, dehydration, osmotic stress, and heavy metal pollution. It also has the potential as a biomarker in health care, as high levels have been found in malignant tumours in breast, endometrial, bone, and gastric cancers. It is also a marker of early stage prostate cancer and cardiac health.
Through a collaboration with Matt Vijayan, an expert on HSP70, the SIMSLab has developed an LSPR-based protein sensor that is able to detect HSP70 without the use of labels. Selective capture of the protein is achieved using an anti-HSP70 antibody bound to functionalized metal nanoparticles. Shift in the LSPR peak position can be used to determine the concentration of HSP70 in a sample. We are currently optimizing the sensor to improve detection limits and develop a handheld version of the device.
Protein sensor for point-of-care medical diagnostics
Currently, the majority of medical labs cannot deliver blood work results within the ideal time, at which diagnosis is most critical and treatment most effective. For example, a bleed-to-read time of thirty minutes is ideal for diagnosis of myocardiac infarction (cardiac arrest). However, even the most advanced hospitals have difficulty obtaining results within one hour. Point-of-care (POC) diagnostics, in which the blood sample is analyzed at the patient bedside rather than being sent to the lab for analysis, offers rapid detection and at a lower cost. This increases hospital throughput, decreases spending, and increases patient diagnosis accuracy and treatment effectiveness.
The SIMSLab is developing multiplexed LSPR sensors for use in POC medical diagnostics (Fig. 16). Specifically, they are developing a sensor for simultaneous detection of four critical markers of myocardial infarction (MI): cTnT, cTnI, CK-MB, and Myoglobin. Detection of these biomarkers simultaenously offers a wealth of information regarding the type and severity of MI, as well as the potential for much earlier diagnosis. This sensor is currently under development and will be updated as progress is made.